Standardization in Molecular Assays
The key to Personalized Therapeutic Strategies
Our Molecular Assays Help in Guiding Decisions
 

AT A GLANCE

IPSOGEN, cancer profiler, develops and markets molecular diagnostic tests designed to map diseases in order to guide patient and oncologists' decisions along their complex therapeutic path.


> See company profile

2nd prize winner of Women Innovators

© European Union

IPSOGEN is very proud to announce that Fabienne Hermitte, Co-founder IPSOGEN Senior Director, Research and Development - Regulatory Affairs, is the 2nd prize winner of the EU Prize for Women Innovators.

 

http://www.surveymonkey.com/s/QJH2NBHMore info
© IPSOGEN  2012